In this study, we explored the major ligands and receptors of the MK signaling pathway, such as MDK-NCL, which were involved in the progression of various cancers, including lung cancer, breast cancer, liver cancer, gastric cancer, and colorectal cancer (110). The gene discussed is MDK; the disease is breast carcinoma.